tolbutamide has been researched along with aspartic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Hasnain, S; Krupa, JC; Ménard, R; Mort, JS; Nägler, DK | 1 |
Flanagan, JU; McLaughlin, LA; Paine, MJ; Roberts, GC; Sutcliffe, MJ; Wolf, CR | 1 |
3 other study(ies) available for tolbutamide and aspartic acid
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
S2' substrate specificity and the role of His110 and His111 in the exopeptidase activity of human cathepsin B.
Topics: Amidohydrolases; Aspartic Acid; Binding Sites; Cathepsin B; Exopeptidases; Glutamic Acid; Histidine; Humans; Ions; Kinetics; Lysosomes; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Protein Binding; Protein Structure, Tertiary; Recombinant Proteins; Substrate Specificity; Tolbutamide | 2002 |
Role of conserved Asp293 of cytochrome P450 2C9 in substrate recognition and catalytic activity.
Topics: Amino Acid Sequence; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antitussive Agents; Aryl Hydrocarbon Hydroxylases; Aspartic Acid; Cytochrome P-450 CYP2C9; Dextromethorphan; Diclofenac; Humans; Hypoglycemic Agents; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutagenesis, Site-Directed; NADPH-Ferrihemoprotein Reductase; Protein Binding; Protein Structure, Secondary; Rabbits; Sequence Alignment; Substrate Specificity; Tolbutamide | 2003 |